Otosclerosis and tinnitus: when the stapes fixes

Sound travels from the eardrum to the inner ear through three tiny bones: the malleus, the incus, and the stapes. The stapes is the smallest bone in the human body, and its job is to transmit vibration across the oval window into the fluid-filled cochlea. In otosclerosis, that job becomes progressively harder as abnormal bone growth slowly anchors the stapes in place.

The result is a distinctive clinical picture: conductive hearing loss that tends to develop in early adulthood, is often bilateral, and commonly comes paired with tinnitus, usually a low-pitched, steady tone rather than the high-pitched ringing associated with cochlear damage.

What is happening at the bone level

Otosclerosis is a disease of the otic capsule, the bony shell that houses the cochlea and vestibular apparatus. Normally, bone within the otic capsule undergoes very little remodeling after fetal development. In otosclerosis, this stability breaks down. Vascular, spongy bone replaces the normally dense otic capsule bone at specific foci, most commonly at the fissula ante fenestram, a small region just anterior to the oval window.

As this abnormal bone encroaches on the oval window, it progressively immobilizes the stapes footplate. When the footplate cannot move freely, the mechanical link between the eardrum and the inner ear is disrupted, and conductive hearing loss results.

The NIDCD notes that otosclerosis affects approximately three million Americans. It is more common in white populations, and women are diagnosed more frequently than men, with a roughly 2:1 ratio. The condition often becomes clinically apparent in the second or third decade of life, though it may not be detected until later.

How hearing loss develops

Because the spongy bone formation is initially focal and then spreads, hearing loss in otosclerosis typically progresses gradually over years. Many patients first notice difficulty in quiet settings, then progressively in more situations. A characteristic early finding on audiometric testing is a notch at 2000 Hz on bone conduction testing, called Carhart’s notch, which reflects the mechanical resonance of the ossicular chain rather than true cochlear loss.

As the disease progresses, the air-bone gap on audiometry widens, reflecting the degree of conductive impairment. In some patients, the spongy bone foci extend toward the cochlear endosteum, producing sensorineural involvement on top of the conductive loss. This mixed pattern is more complex to manage and may affect surgical outcomes.

Bilateral involvement is common. The NIH StatPearls review notes that approximately 70 to 80 percent of patients with clinical otosclerosis have bilateral disease, though the two ears often progress at different rates.

Tinnitus in otosclerosis

Tinnitus is reported by a substantial proportion of patients with otosclerosis, with some studies citing rates above 50 percent. The character of otosclerosis-associated tinnitus tends to differ from the high-pitched ringing typical of noise-induced or age-related cochlear damage.

Otosclerosis tinnitus is often described as low-pitched, roaring, or humming. This matches the audiometric profile of the condition, in which low-frequency hearing is disproportionately affected early in the disease. Patients sometimes describe it as similar to the sound of blood rushing, which can overlap clinically with pulsatile tinnitus, though true pulsatile tinnitus warrants separate investigation.

The mechanism linking otosclerosis to tinnitus is not definitively established. One hypothesis involves the enzymatic activity of the abnormal bone affecting cochlear fluid dynamics. Another relates to the pattern of conductive loss prompting central auditory compensation. What is well documented clinically is that successful surgical restoration of ossicular mobility often reduces or eliminates tinnitus, suggesting a close mechanical relationship.

Diagnosis

The classic diagnostic workup begins with audiometry. The combination of a conductive hearing loss pattern, a widened air-bone gap, and a Carhart’s notch is strongly suggestive. Tympanometry typically shows a normal or slightly reduced tympanogram (type As, with reduced compliance), reflecting the stiffened ossicular chain. This distinguishes otosclerosis from middle-ear effusion, in which the tympanogram is typically flat (type B).

Imaging is not always required for diagnosis but is used when the clinical picture is atypical or when cochlear involvement is suspected. CT of the temporal bone can visualize the characteristic halos of decreased bone density around the cochlea (cochlear otosclerosis or otospongiosis).

An ENT specialist or otologist typically confirms the diagnosis and discusses management options.

Treatment: surgery and amplification

Stapedectomy and stapedotomy are the primary surgical options. In a stapedectomy, the fixed stapes is removed and replaced with a prosthesis. In the more commonly performed stapedotomy, a small hole is made in the stapes footplate and a piston prosthesis is inserted. Both procedures aim to restore mechanical transmission across the oval window.

Surgical outcomes for conductive hearing loss are generally good. Studies report closure of the air-bone gap to within 10 dB in a majority of well-selected patients. As noted, many patients also experience improvement in tinnitus, though this is not guaranteed. Surgical risks include a small chance of worsening sensorineural hearing loss, which is discussed with patients preoperatively.

Sodium fluoride has historically been proposed to slow the progression of otosclerosis by modifying bone metabolism. Evidence for its efficacy is limited and mixed, and it is not widely endorsed in current clinical practice. Its use has diminished as surgical and amplification options have improved.

Hearing aids remain a valid, effective option, particularly for patients who prefer to avoid surgery or who have mixed loss in which the sensorineural component limits the potential benefit of conductive surgery. Bone-anchored hearing aids (BAHA) are another option, especially when ear anatomy makes conventional aids difficult.

What to expect over time

Otosclerosis is generally a slowly progressive condition. Without treatment, hearing loss typically worsens over years. With successful surgery, hearing improvement is usually stable long-term, though the underlying disease process continues and can sometimes affect the non-operated ear or the cochlear component of the treated ear.

Patients with a family history of otosclerosis sometimes seek evaluation before noticeable symptoms develop. Because the earliest audiometric changes can be subtle, serial monitoring in high-risk individuals is a reasonable approach, discussed with an otologist.

If symptoms persist or change, see an audiologist or physician.